Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
28
pubmed:dateCreated
2004-7-14
pubmed:databankReference
pubmed:abstractText
Prion diseases are associated with the conversion of the alpha-helix rich prion protein (PrPC) into a beta-structure-rich insoluble conformer (PrPSc) that is thought to be infectious. The mechanism for the PrPC-->PrPSc conversion and its relationship with the pathological effects of prion diseases are poorly understood, partly because of our limited knowledge of the structure of PrPSc. In particular, the way in which mutations in the PRNP gene yield variants that confer different susceptibilities to disease needs to be clarified. We report here the 2.5-A-resolution crystal structures of three scrapie-susceptibility ovine PrP variants complexed with an antibody that binds to PrPC and to PrPSc; they identify two important features of the PrPC-->PrPSc conversion. First, the epitope of the antibody mainly consists of the last two turns of ovine PrP second alpha-helix. We show that this is a structural invariant in the PrPC-->PrPSc conversion; taken together with biochemical data, this leads to a model of the conformational change in which the two PrPC C-terminal alpha-helices are conserved in PrPSc, whereas secondary structure changes are located in the N-terminal alpha-helix. Second, comparison of the structures of scrapie-sensitivity variants defines local changes in distant parts of the protein that account for the observed differences of PrPC stability, resistant variants being destabilized compared with sensitive ones. Additive contributions of these sensitivity-modulating mutations to resistance suggest a possible causal relationship between scrapie resistance and lowered stability of the PrP protein.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-10079068, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-10220323, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-10806380, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-10899999, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-10900000, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-11458009, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-11524679, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-11546838, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-11577109, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-11891310, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-12034448, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-12082114, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-12270715, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-12271119, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-12552009, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-12621436, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-12778138, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-12826672, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-15037077, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-15299354, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-1969635, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-4760134, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-7595360, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-7902575, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-8100741, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-8700211, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-8922485, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-8994041, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-9223277, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-9356250, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-9391046, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-9462739, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-9519302, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-9757107, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-9811807, http://linkedlifedata.com/resource/pubmed/commentcorrection/15240887-9870592
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
13
pubmed:volume
101
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
10254-9
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Insight into the PrPC-->PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants.
pubmed:affiliation
Laboratoire d'Enzymologie et de Biochimie Structurales, Centre National de la Recherche Scientifique, 91198 Gif sur Yvette, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't